Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Aug 04, 2023 12:02pm
169 Views
Post# 35573465

RE:RE:RE:Nothing stellar about this p.r. release

RE:RE:RE:Nothing stellar about this p.r. release

As they have noted on several occasssions for those who have been paying attention, there were two main obstacles preventing some of their potentital customers from signing off on long term QAPs contracts:

1. Significant cash in the bank to demonstrate financial health
2. Systems in place to execute on significantly higher volumes of orders than they have typically delivered across multiple SKUs 

Keep in mind that MBX products will be critical to the success of these multi million dollar product launches of their customers, they need to be certain they are partnering with a world class and long term supplier. Both of these obstacles are now removed, and this PR is  "official" notice. The wait is over, expect some more exciting news soon. 

<< Previous
Bullboard Posts
Next >>